MedPath

Western History Collection

Western History Collection logo
πŸ‡ΊπŸ‡ΈUnited States
Ownership
Private
Established
1890-01-01
Employees
10K
Market Cap
-
Website
http://www.ou.edu

Clinical Trials

394

Active:21
Completed:201

Trial Phases

6 Phases

Early Phase 1:16
Phase 1:31
Phase 2:40
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (328 trials with phase data)β€’ Click on a phase to view related trials

Not Applicable
212 (64.6%)
Phase 2
40 (12.2%)
Phase 1
31 (9.5%)
Phase 4
19 (5.8%)
Early Phase 1
16 (4.9%)
Phase 3
10 (3.0%)

Cigar Legislation and Regulation in Tobacco for the Young (Project CLARITY)

Not Applicable
Not yet recruiting
Conditions
Cigar Smoking
Tobacco Use
First Posted Date
2025-09-09
Last Posted Date
2025-09-09
Lead Sponsor
University of Oklahoma
Target Recruit Count
300
Registration Number
NCT07162935
Locations
πŸ‡ΊπŸ‡Έ

West Virginia University, Morgantown, West Virginia, United States

Feasibility Study for Repurposing RET Inhibitors

Not Applicable
Not yet recruiting
Conditions
Cachexia-Anorexia Syndrome
Interventions
Other: Strength Assessment
First Posted Date
2025-08-28
Last Posted Date
2025-09-10
Lead Sponsor
University of Oklahoma
Target Recruit Count
7
Registration Number
NCT07146893
Locations
πŸ‡ΊπŸ‡Έ

OU Health Stephenson Cancer Center, Oklahoma City, Oklahoma, United States

Improving Rates of Diagnostic Colonoscopy in Native Americans

Not Applicable
Not yet recruiting
Conditions
CRC Screening
CRC (Colorectal Cancer)
First Posted Date
2025-08-11
Last Posted Date
2025-08-11
Lead Sponsor
University of Oklahoma
Target Recruit Count
164
Registration Number
NCT07115875
Locations
πŸ‡ΊπŸ‡Έ

TSET Health Promotion Research Center, Oklahoma City, Oklahoma, United States

Trial of Varenicline With Nicotine Lozenges and a Smartphone Medication Adherence Intervention for Smoking Cessation

Not Applicable
Not yet recruiting
Conditions
Smoking Cessation
Interventions
Drug: Varenicline (VAR)
Drug: Nicotine lozenge (NRT)
Behavioral: Smartphone intervention with adherence components (ADHERE)
Behavioral: Telephone Counseling
Behavioral: Smartphone intervention without adherence components (NO ADHERE)
First Posted Date
2025-08-01
Last Posted Date
2025-08-28
Lead Sponsor
University of Oklahoma
Target Recruit Count
496
Registration Number
NCT07099638
Locations
πŸ‡ΊπŸ‡Έ

TSET Health Promotion Research Center, Oklahoma City, Oklahoma, United States

Oklahoma Study of Native American Pain Risk IV: Smoking Cessation and Pain

Not Applicable
Not yet recruiting
Conditions
Smoking Cessation Intervention
Pain
Smoking (Tobacco) Addiction
First Posted Date
2025-07-23
Last Posted Date
2025-07-23
Lead Sponsor
University of Oklahoma
Target Recruit Count
150
Registration Number
NCT07080788
Locations
πŸ‡ΊπŸ‡Έ

University of Oklahoma - Schusterman Center, Tulsa, Oklahoma, United States

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 79
  • Next

News

University of Oklahoma Researchers Unlock Amylin Receptor Mechanisms for Next-Generation Obesity Drugs

University of Oklahoma researchers published breakthrough findings in Science Signaling revealing new understanding of how amylin receptors function, providing crucial insights for obesity drug development.

Smart-T Smoking Cessation App Shows Nearly Double Quit Rates in Low-Income Adults

University of Oklahoma researchers developed Smart-T, a real-time adaptive smartphone app that nearly doubled smoking cessation rates compared to a static app in a clinical trial of 454 low-income smokers.

Novel Hafnium-Based Treatment Trial Launches for Cisplatin-Ineligible Head and Neck Cancer Patients

International researchers launch NANORAY-312 trial investigating hafnium metal therapy combined with radiation as a novel treatment approach for head and neck cancer patients unsuitable for cisplatin treatment.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.